Tissue heating and ablation systems and methods which predict maximum tissue temperature

Information

  • Patent Grant
  • 6652513
  • Patent Number
    6,652,513
  • Date Filed
    Monday, September 24, 2001
    24 years ago
  • Date Issued
    Tuesday, November 25, 2003
    21 years ago
Abstract
Systems and methods heat or ablate body tissue by positioning an electrode to transmit heat or ablation energy to a tissue region. The systems and methods measure a first temperature using a temperature sensing element associated with the electrode. The systems and methods also measure a second temperature using a temperature sensing element associated with the electrode. The systems and methods process at least one of the first and second temperatures to derive a prediction of maximum temperature of the tissue region. The systems and methods generate an output that controls the transmission of the heating or ablation energy based, at least in part, upon the maximum tissue temperature prediction.
Description




FIELD OF THE INVENTION




In a general sense, the invention is directed to systems and methods for creating lesions in the interior regions of the human body. In a more particular sense, the invention is directed to systems and methods for ablating heart tissue for treating cardiac conditions.




BACKGROUND OF THE INVENTION




Physicians frequently make use of catheters today in medical procedures to gain access into interior regions of the body. In some procedures, the catheter carries an energy transmitting element on its distal tip to ablate body tissues.




In such procedures, the physician must establish stable and uniform contact between the energy transmitting element and the tissue to be ablated. Upon establishing contact, the physician must then carefully apply ablating energy to the element for transmission to the tissue.




The need for precise control over the transmission of ablation energy is especially critical during catheter-based procedures for ablating heart tissue. These procedures, called electrophysiology therapy, are becoming increasingly more widespread for treating cardiac rhythm disturbances, called arrhythmias. Cardiac ablation procedures typically use radio frequency (RF) energy to form a lesion in heart tissue.




The principal objective of the invention is to provide systems and methods for monitoring and reliably controlling the application of energy to ablate body tissue, thereby providing therapeutic results in a consistent and predictable fashion.




SUMMARY OF THE INVENTION




The invention provides systems and methods that provide reliable control over tissue heating and ablation procedures using temperature sensing.




The systems and methods heat or ablate body tissue by positioning an electrode to transmit heat or ablation energy to a tissue region. The systems and methods measure a first temperature using a temperature sensing, element associated with the electrode. The systems and methods also measure a second temperature using a temperature sensing element associated with the electrode. The systems and methods process at least one of the first and second temperatures to derive a prediction of maximum temperature of the tissue region.




In a preferred embodiment, the systems and methods generate an output that controls the transmission of the heating or ablation energy based, at least in part, upon the maximum tissue temperature prediction.




Other features and advantages of the inventions are set forth in the following Description and Drawings, as well as in the appended claims.











BRIEF DESCRIPTION OF THE DRAWINGS





FIG. 1

is a perspective view of a system for ablating tissue that comprises an energy emitting electrode and associated energy generator;





FIGS. 2

,


3


and


4


are, respectively, an elevated side view, an end view, and a side section view (taken along line


4





4


in

FIG. 3

) of the electrode associated with the system shown in

FIG. 1

, the electrode having two temperature sensing elements;





FIG. 5

is a schematic view of the generator for supplying energy to the electrode in the system shown in

FIG. 1

, the generator using a specialized modified PID control technique to maintain a desired set temperature by altering power in response to a prediction of maximum tissue temperature;





FIG. 6

is a schematic view of a device used to experimentally determine the relationship between maximum tissue temperature and the temperatures sensed by two sensing elements carried by an electrode;





FIG. 7A

is a graph presenting a comparison, for an electrode-tissue angle of 90°, of the temperature variations with time when the actual highest tissue temperature controlled the application of radio frequency energy compared when a predicted maximum tissue temperature, calculated according to the invention, was used as the control input;





FIG. 7B

is a graph presenting a comparison of applied power versus time under the same conditions set forth in

FIG. 7A

;





FIG. 8A

is a graph presenting a comparison, for an electrode-tissue angle of 0°, of the temperature variations with time when the actual highest tissue temperature controlled the application of radio frequency energy compared when a predicted maximum tissue temperature, calculated according to the invention, was used as the control input;





FIG. 8B

is a graph presenting a comparison of applied power versus time under the same conditions set forth in

FIG. 8A

;





FIG. 9

is a schematic view of the implementation of a neural network predictor to predict maximum tissue temperature;





FIG. 10

is a representative single-perception network that can be used to predict maximum tissue temperature according to the invention;





FIG. 11

is a graph presenting a comparison, for an electrode-tissue angle of 90°, of the temperature variations with time when the actual highest tissue temperature controlled the application of radio frequency energy compared when the predicted maximum tissue temperature output of the network shown in

FIG. 10

was used as the control input;





FIG. 12

is a schematic view of the implementation of fuzzy logic to predict maximum tissue temperature; and





FIG. 13

is a flexible, multiple electrode element with multiple temperature sensing elements that can be used to predict maximum tissue temperature according to the invention;





FIG. 14

is an electrode with multiple temperature sensing elements, and a heating element to heat the electrode, which can be used to predict maximum tissue temperature according to the invention;





FIG. 15

is an alternative embodiment of an electrode with multiple temperature sensing elements and a heating element which can be used to predict maximum tissue temperature according to the invention;





FIG. 16

is a system including an electrode like that shown in either

FIG. 14

or

FIG. 15

, which can be used to predict maximum tissue temperature according to the invention; and





FIGS. 17 and 18

are schematic views of a system for controlling the application of ablation energy to multiple electrodes using multiple predicted maximum tissue temperature inputs.











The invention may be embodied in several forms without departing from its spirit or essential characteristics. The scope of the invention is defined in the appended claims, rather than in the specific description preceding them. All embodiments that fall within the meaning and range of equivalency of the claims are therefore intended to be embraced by the claims.




DESCRIPTION OF THE PREFERRED EMBODIMENTS





FIG. 1

shows a system


10


for ablating human tissue that embodies the features of the invention.




In the illustrated and preferred embodiment, the system


10


includes a generator


12


that delivers radio frequency energy to ablate tissue. Of course, other types of energy can be generated for tissue ablating purposes.




The system


10


also includes a steerable catheter


14


carrying a radio frequency transmitting ablation electrode


16


. In the illustrated embodiment, the ablation electrode


16


is made of platinum.




In the illustrated embodiment, the system


10


operates in a unipolar mode. In this arrangement, the system


10


includes a skin patch electrode that serves as an indifferent second electrode


18


. In use, the indifferent electrode


18


attaches to the patient's back or other exterior skin area.




Alternatively, the system


10


can be operated in a bipolar mode. In this mode, the catheter


14


carries both electrodes.




The system


10


can be used in many different environments. This specification describes the system


10


when used to provide cardiac ablation therapy.




When used for this purpose, a physician steers the catheter


14


through a main vein or artery (typically the femoral vein or artery) into the interior region of the heart that is to be treated. The physician then further manipulates the catheter


14


to place the electrode


16


into contact with the tissue within the heart that is targeted for ablation. The user directs radio frequency energy from the generator


12


into the electrode


16


to ablate and form a lesion on the contacted tissue.




In the embodiment shown in

FIG. 1

, the catheter


14


includes a handle


20


, a catheter body


22


, and a distal tip


24


, which carries the electrode


16


.




The handle


20


encloses-a steering mechanism


26


for the catheter tip


24


. A cable


28


extending from the rear of the handle


20


to connect the catheter


14


to the generator


12


for conveying radio frequency energy to the ablation electrode


16


via a signal wire


29


(see FIG.


4


).




Left and right steering wires


54


(see

FIG. 4

) are connected to a steering spring


52


at the tip of the catheter body


22


. The steering wires extend through the catheter body


22


to interconnect the steering mechanism


26


in the handle


20


(see FIG.


1


). Rotating the steering mechanism


26


to the left pulls on the left steering wire, causing the spring


52


and tip


24


to bend to the left. In the same way, rotating the steering mechanism


26


to the right causes the spring


52


and tip


24


to bend to the right. In this way, the physician steers the ablation electrode


16


into contact with the tissue to be ablated.




Further details of this and other types of steering mechanisms for the ablating element


10


are shown in Lunquist and Thompson U.S. Pat. No. 5,254,088, which is incorporated into this Specification by reference.




I. Multiple Temperature Sensing




As

FIGS. 2

to


4


show, the ablation electrode


16


carries two temperature sensing elements


30


and


32


. As will be described in greater detail later, the power that the generator


12


applies to the electrode


16


is set, at least in part, by the temperature conditions sensed by the elements


30


and


32


.




As best shown

FIGS. 3 and 4

, the ablation electrode


16


includes an interior well


34


extending through its center. The two temperature sensing elements


30


and


32


occupy this well


34


.




In the illustrated embodiment, the first temperature sensing element


30


is carried within a cap


42


at the distal extremity of the well


34


. In use, the sensing element


30


is intended to make thermal conductive contact with tissue, to thereby sense tissue temperature.




Lead wires


38


extend from the sensing element


30


through the catheter body


22


into the catheter handle


20


. There, the lead wires


38


electrically couple to the cable


28


for connection to the generator


12


. The lead wires


38


transmit the tissue temperature signals from the temperature sensing element


30


to the generator


12


.




In the illustrated and preferred embodiment, the sensing element


30


comprises a conventional small bead thermistor


40


. For example, a 0.55 mm bead thermistor commercially available from Thermometrics (Edison, N.J.), Part Number AB6B2-GC16KA143E/37° C-A can be used.




The sensing element


30


and lead wires


38


are electrically insulated from the surrounding ablation electrode


16


. For this purpose, electrically insulating potting compound, such as heavy isomid, cyanoacrylate adhesive, silicon rubber RTV adhesive, polyurethane, epoxy, or the like, encapsulates the thermistor bead


40


in conventional fashion. The lead wires


38


are likewise enclosed in electrically insulating sheaths made from, for example, polyimide material, although other conventional electrical insulating materials also can be used.




The cap


42


is made from a thermal conducting material having a high thermal conductivity that is at least 1.0 watt (W) per meter (m) Kelvin (K), or 1.0 W/m K. Metallic materials like stainless steel, gold, silver alloy, platinum, copper, nickel, titanium, aluminum, and compositions containing stainless steel, gold, silver, platinum, copper, nickel, titanium, and aluminum possess this degree of thermal conductivity. The encapsulated thermistor bead


40


is preferably potted within the cap


42


using an electrically insulating epoxy having an enhanced thermal conductivity that is at least 1.0 W/m K. The inclusion of a metallic paste (for example, containing aluminum oxide) in a standard epoxy material will provide this enhanced thermal conductivity.




The cap


42


is fitted within the well


34


of the electrode


16


with its distal end


44


making thermal conductive contact with the tissue. The high thermal conductivity of the cap material assures that the cap


42


will quickly reach an equilibrium temperature close to that of the tissue it contacts.




In the illustrated and preferred embodiment, a thermal and electrically insulating barrier


46


forms an interface between the interior wall of the well


34


and the side of the cap


42


that occupies it. In a preferred embodiment, the barrier


46


comprises polyamide adhered about the sidewall of the cap


42


using FMD-14 to serve as an electrical insulator. The barrier


46


also comprises polyester shrink tubing secured by heat shrinking about the polyamide to serve as a thermal insulator. In the illustrated and preferred embodiment, the thermistor-containing cap


42


and associated barrier


46


are affixed and potted within the electrode well using cyanoacrylate FMD-13 (Loctite Corporation, Newington, Conn.).




The thermal conducting cap


42


creates an isothermal condition about the sensing element


30


close to the actual temperature of the tissue it contacts. Furthermore, the cap


42


, being substantially isolated from thermal conductive contact with the electrode


16


, retains this isothermal condition about sensing element


30


, preventing its dissipation by the thermal mass of the electrode


16


. Further details of the use and construction of the thermal conducting cap


42


are found in copending U.S. patent application Ser. No. 08/432,321, filed May 1, 1995, and entitled “Systems and Apparatus for Sensing Temperature in Body Tissue”, which is incorporated herein by reference.




The second temperature sensing element


32


carried within the well


34


is connected by soldering or by thermal conductive adhesive in direct thermal conductive contact with the thermal mass of the electrode


16


. While transmitting radio-frequency energy to heat surrounding tissue, the electrode


16


is heated by thermal conduction from the heated tissue. In use, the second sensing element


32


is intended to sense the temperature of the electrode


16


due to conductive heat transfer.




In the illustrated and preferred embodiment, the sensing element


32


also comprises a conventional small bead thermistor


48


, as already described in connection with the sensing element


30


. Also, like the sensing element


30


, the sensing element


32


is electrically insulated from the electrode


16


by encapsulation in an electrically insulating potting compound, as also already described.




The thermistor


48


also has associated lead wires


50


, which extend through the catheter body


22


and handle


20


to the cable


28


. The cable


28


transmits the electrode temperature signals from the temperature sensing element


32


to the generator


12


.




It should be appreciated that the first temperature sensing element


30


need not be positioned in thermal conductive contact with tissue. The first element


30


can, like the second element


32


, be positioned in thermal conductive contact with the electrode


16


. It is also not necessary that one or both sensing elements


30


and


32


be in direct thermal conductive contact with the electrode


16


. The invention requires only that the two temperature sensing elements


30


and


32


be positioned relative to the electrode


16


in a spaced apart condition to measure a meaningful spatial temperature gradient at the tissue-electrode interface.




It should also be appreciated that the electrode


16


need not be in direct contact with tissue. Laser and microwave transmitting electrodes can carry the spaced apart temperature sensing elements


30


and


32


and perform tissue ablation according to invention without contacting the ablated tissue.




The apparatus and methods that embody the features of the invention are well suited for use in the field of cardiac ablation, which the preferred embodiments exemplify. Still, the invention is applicable for use in tissue heating applications, as well. For example, the various aspects of the invention have application in procedures for ablating or heating tissue in the prostrate, brain, gall bladder, uterus, and other regions of the body, using systems that are not necessarily catheter-based.




It should be appreciated that other types of temperature sensing elements can also be used. For example, a thermocouple could be used as the temperature sensing element. In a preferred implementation, the thermocouples are constructed by either spot welding or by laser stripping and welding the different metals together to form the thermocouple junction. When a thermocouple serves as the temperature sensing element, a reference thermocouple must be used. The reference thermocouple may be placed in the handle


20


, generator


12


, or exposed to the blood pool in the manner disclosed in copending U.S. patent application Ser. No. 08/286,937, filed Aug. 8, 1994, and entitled “Systems and Methods for Sensing Temperature Within the Body.”




Electrical insulation is also required when thermocouples are used as the temperature sensors. For example, the thermocouple junction can be placed in a thermally conducting epoxy inside a polyester sleeve. In a preferred implementation, the thermocouple junction is placed in UV modified acrylic adhesive 330 (Loctite Corporation, Newington, Conn.) within a shrink polyester sleeve, which is then shrunk to fit tightly about the thermocouple junction and wires. To reduce electrical interference, the thermocouple wires are also preferably electrically shielded and twisted together.




II. THE RF GENERATOR




As

FIG. 5

shows, the generator


12


includes a radio frequency power source


56


connected through a main isolation transformer


58


to outlet and return lines


60


and


62


. Outlet line


60


leads to the ablation electrode


16


. Return line


62


leads from the indifferent electrode


18


.




In the illustrated embodiment, when used for cardiac ablation, the power source


56


is typically conditioned to deliver up to 150 watts of power at a radio frequency of 500 kHz.




The generator


12


further includes a temperature acquisition system


64


, a temperature processing element


66


, a demand power processor


68


, and a converter


70


. These components comprise a feedback loop, which couples the two temperature sensing elements


30


and


32


to the source


56


for making applied radio-frequency energy responsive to sensed temperature conditions.




The temperature acquisition system


64


is coupled to the two temperature sensing elements


30


and


32


. The system


64


continuously samples at prescribed time periods, t, the analog signals generated by the sensing elements


30


and


32


based upon sensed temperature conditions. The system


64


converts the separate analog signals of the sensing elements


30


and


32


into individual, proportional digital signals, respectively tissue temperature T


1


(t) and electrode temperature T


2


(t).




The temperature processing element


66


is coupled to the temperature acquisition system


64


to receive as input the digital signals tissue temperature T


1


(t) and electrode temperature T


2


(t). The processing element


66


applies prescribed criteria to these actual temperature signals to derive, for the sampled time interval, a prediction of the hottest tissue temperature present in the tissue region in the vicinity of the electrode


16


, T


pred


(t).




The demand power processor


68


periodically compares T


pred


(t) to a set temperature value T


set


. The set temperature value T


SET


can be inputted by the physician through an interface


72


. The set temperature value T


SET


represents the maximum tissue temperature the physician wants to maintain at the ablation site. The value T


SET


can be established in other ways. For example, the value T


SET


can vary over time to define a set temperature curve.




The set temperature value T


SET


selected depends upon the desired therapeutic characteristics of the lesion. Typical therapeutic lesion characteristics are the surface area of the tissue that is ablated and depth of the ablation. Typically, the set temperature T


SET


is in the range of 50 to 90 degrees C.




Based upon this comparison, and preferably taking into account the magnitude of the instantaneous power P(t) supplied to the ablating electrode


16


, the processor


68


derives the demand power output P


DEMAND


(t). The demand power output P


DEMAND


(t) represents the magnitude of the radio frequency power that should be supplied to the ablating electrode


16


to establish or maintain the desired local temperature condition T


SET


at the ablating electrode


16


. By taking into account the magnitude of the instantaneous power P(t), the processor


68


assures that a prescribed maximum power level P


MAX


is not exceeded.




The manner in which the processor


68


derives P


DEMAND


(t) can vary. For example, it can employ proportional control principles, proportional integral derivative (PID) control principles, adaptive control, neural network, and fuzzy logic control principles.




EXAMPLE 1




The following Example 1 shows an exemplary core PID control algorithm that the processor


68


can employ for controlling power based upon predicted tissue temperature.




In this example, K


p


, K


d


, and K


i


are, respectively, the proportional, derivative, and integral coefficients of the PID algorithm used for controlling power based on predicted tissue temperature. The same algorithm was used to control actual tissue temperature in the comparisons presented in

FIGS. 7

A/B and


8


A/B, to be discussed in greater detail later.




In this algorithm, the power at time t+1 is controlled based upon the difference between the temperature and the set temperature at times t, t−1, and t−2 (expressed in Kelvin or degrees Celsius), as follows:






power (


t+


1)=7


W*{K




p


*(


T


(


t


)−


T




SET


)+


K




d


*[(


T


(


t


)−


T




SET


)−(


T


(


t−


1)−


T




SET


)]+


K




i


*[(


T


(


t


)−


T




SET


)+(


T


(


t


−1)−


T




SET


)+(


T


(


t−


2)−


T




SET


)]}






Data collected from the finite element analysis presented below (in Section III(A)) demonstrates that the following coefficients can be used:




K


p


=0.04




K


i


=0.005




K


d


=0.008




The multiplier “7W” appearing in the above algorithm reflects that the finite element analysis, from which the coefficients were derived, computed the power-to-temperature transfer function of the modeled system at a 7 watt (W) level.




The foregoing example sets forth the core of the control algorithm for deriving p(I) (i.e., P


Demand


, based upon a fixed value of T


SET


. The algorithm can include other auxiliary features.




For example, T


SET


can be expressed as a function with respect to time, which can be linear, or nonlinear, or both.




As another example, P


Demand


derived by the algorithm can be compared to a maximum power condition. Should P


Demand


exceed the maximum power condition, the controller


68


blocks passage of P


Demand


and instead commands a preestablished low power condition until P


Demand


becomes less than the maximum power.




Other representative implementations are disclosed in copending patent application Ser. No. 08/266,934, filed Jun. 27, 1994, and entitled “Tissue Heating and Ablation Systems and Methods Using Predicted Temperature for Monitoring and Control.”




The converter


70


derives a command voltage signal V


DEMAND


(t) based upon the demand power output P


DEMAND


(t). The command voltage signal V


DEMAND


(t)adjusts the amplitude of the voltage V


(t)


supplied to the source


56


to thereby adjust P


(t)


. Alternatively, the converter


70


could derive a command current signal I


DEMAND(t)


based upon the demand power output P


DEMAND


(t) to adjust the amplitude of the current supplied to the source


56


, achieving the same results.




The manner in which the converter


70


generates V


DEMAND


(t) to adjust P(t) can vary. For example, the converter


70


can employ proportional control principles, proportional integral derivative (PID) control principles, neural network, fuzzy logic, and adaptive control principles. Representative implementations are disclosed in copending patent application Ser. No. 08/266,934, filed Jun. 27, 1994, and entitled “Tissue Heating and Ablation Systems and Methods Using Predicted Temperature for Monitoring and Control.”




III. Deriving T


PRED


(t)




A. Prediction Based Upon An Analytical Function




The quantity T


PRED


can be expressed in terms of an analytical function f(T


1


, T


2


), which sets forth, for a given electrode geometry, the variation of hottest tissue temperature T


MAX


with sensed tissue temperature T


1


and sensed electrode temperature T


2


. The function is determined for a given electrode geometry by tabulating in vitro or in vivo results, measuring T


1


, T


2


, and T


MAX


, and generating finite element models for the same electrode geometries to estimate T


PRED


, until the modeled T


PRED


≈measured T


MAX


.




EXAMPLE 2




Determining an Analytical T


PRED


Function




A three-dimensional finite element model is created for an 8F diameter/5 mm long radio frequency ablation electrode placed in a blood pool in contact with an approximately 4 cm thick rectangular slice of cardiac tissue at tissue-electrode angles of 0° and 90°. The electrode has two temperature sensing elements, as shown in

FIGS. 2

to


4


, one electrically and thermally isolated at the tip for sensing tissue temperature and the other electrically isolated but in thermal conductive contact with the electrode for sensing electrode temperature. The tip of the electrode extends about 1.3 mm into the tissue. The overall volume is a parallelpiped 8 cm long, 4 cm wide, and 4 cm thick. The model has 8144 nodes, using hexahedral elements and a nonuniform mesh.




The current density boundary conditions are set at the electrode, so that the maximum tissue temperature (T


MAX


) reaches about 95° C. after 120 seconds.




COSMOS is used on a Hewlett Packard workstation to perform the electrical-thermal, transient analyses for 120 seconds. The analyses estimate the function that defines the relationship between T


1


, T


2


, and the predicted maximal tissue temperature.




The model results are corroborated with experimental data acquired using the apparatus shown in

FIG. 6. A

4 cm thick slice of bovine heart H is fixed in good contact with a 144 cm


2


patch electrode EP inside a tank T filled with saline at 37° C. An ablation catheter C carrying an 8F diameter/5 mm long electrode E is placed in contact with the tissue surface H at an angle of 0° and 90°. A 0.55 mm bead thermistor TM


1


is placed at the electrode tip (to sense T


1


), another 0.55 mm bead thermistor TM


2


is placed within the electrode (to sense T


2


), and a third thermistor TM


3


is placed in the cardiac tissue H about 0.5 mm beneath the electrode tip, which corresponds to the hottest tissue temperature region predicted by the finite element simulations. The thermistor readings are acquired at a sampling rate of 20 ms by LabView running on a Power Mac. A 500 kHz sinusoidal signal is applied between the ablation and indifferent electrodes using a 150 W RF ablation system AS. The delivered RF power (P) is kept constant at 7 W.




Using the above-described methodology, the following function was determined to yield good results for the 8F/5 mm electrode:






T


pred


(t)=4.03*T


1


(t)−2.97*T


2


(t)






The above-described methodology can be used to derive the function for other electrode geometries, as well.




The behavior of the function for an 8F/5 mm electrode is acceptable at both tissue-electrode angles of 0° and 90°.

FIG. 7A

presents a comparison, for an electrode-tissue angle of 90°, of the temperature variations with time when the actual highest tissue temperature controlled the application of radio frequency energy compared when T


pred


, calculated according to the above function, was used as the control input, using the PID control algorithm like that disclosed above.

FIG. 7B

presents a comparison of applied power versus time under the same conditions.

FIGS. 8A and 8B

present similar comparisons for a tissue-electrode angle of 0°. Both comparisons show that any overshoot and settling time will, in time, converge to zero.




Since the data reflected in

FIGS. 7B and 8B

are based upon a finite element analysis conducted at 7 W, the numbers on the y-axis shown in

FIGS. 7B and 8B

should be multiplied by 7 W to obtain the true power levels.





FIGS. 7B and 8B

also show that keeping the temperature at a fixed set value requires a continuous, slow ramping down of applied power. This is because the temperature of heart tissue, when heated at a constant applied power, does not actually reach a steady state below 100° C. Instead, maximum tissue temperature is observed to continuously increase at a slow rate until it reaches 100° C., at which time micro-explosions occur. This rate is defined by the expression:









T



t


=



1

ρ
·
c




j
·
E



0











where:




T is tissue temperature.




t is time.




∂T/∂t is the first temporal derivative of the temperature.




ρ is tissue density.




c is heat capacity of the tissue.




j is current density.




E is electric field intensity.




As

FIGS. 7B and 8B

show, there is, for a given electrode geometry and electrode-tissue angle, a determinable rate at which power decreases to maintain a predicted maximum tissue temperature. In

FIG. 7B

, the rate is 0.008 W/sec for an 8F/5 mm electrode and a 90° tissue-electrode angle. In

FIG. 8B

, the rate is 0.003 W/sec for an 8F/5 mm electrode and a 0° tissue-electrode angle. The temperature processor


66


can ascertain this power-down rate upon deriving T


PRED


(t) using preestablished look-up tables. The processor


66


can generate the power-down rate as output to the demand power processor


68


, instead of T


PRED


(t). The processor


68


would control predicted tissue temperature by ramping down the power transmitted by the electrode based upon the power-down rate.




B. Prediction Based Upon Neural Networks




The dependence of maximum tissue temperature on T


1


and T


2


can also be approximated using neural networks.

FIG. 9

shows an implementation of a neural network predictor


300


, which receives as input the temperatures T


1


(t) and T


2


(t) sensed at the electrode. The predictor


300


outputs a predicted temperature of the hottest tissue region T


PRED


(t).




The predictor


300


uses a two-layer neural network, although more or less hidden layers could be used. As shown in

FIG. 9

, the predictor


300


includes first and second hidden layers and four neurons, designated N(L,X), where L identifies the layer


1


or


2


and X identifies a neuron on that layer. The first layer (L=1) has three neurons (X=1 to 3), as follows N(


1


,


1


); N(


1


,


2


); and N(


1


,


3


). The second layer (L=2) comprising one output neuron (X=1), designated N(


2


,


1


).




Temperature readings from the multiple sensing elements are weighed and inputted to each neuron N(


1


,


1


); N(


1


,


2


); and N(


1


,


3


) of the first layer.

FIG. 9

represents the weights as W


L


(k,N), where L=1; k is the input sensor order; and N is the input neuron number


1


,


2


, or


3


of the first layer.




The output neuron N(


2


,


1


) of the second layer receives as inputs the weighted outputs of the neurons N(


1


,


1


); N(


1


,


2


); and N(


1


,


3


).

FIG. 9

represents the output weights as W


L


(O,X), where L=2; O is the output of neuron


1


,


2


, or


3


of the first layer; and X is the input neuron number of the second layer. Based upon these weighted inputs, the output neuron N(


2


,


1


) predicts T


PRED


(t). Alternatively, a sequence of past reading samples from each sensor could be used as input. By doing this, a history term would contribute to the prediction of the hottest tissue temperature.




The predictor


300


must be trained on a known set of data containing the temperature of the sensing elements T


1


and T


2


and the temperature of the hottest region, which have been previously acquired experimentally in the manner set forth in the foregoing example. For example, using a back-propagation model, the predictor


300


can be trained to predict the known hottest temperature of the data set with the least mean square error. Once the training phase is completed, the predictor


300


can be used to predict T


PRED


(t)




EXAMPLE 3




Tissue Temperature Prediction Using Neural Networks





FIG. 10

shows a single perceptron network


302


with inputs T


TIP


(t) and T


CENTER


(t) corresponding with temperatures sensed by sensing element


30


and sensing element


32


, respectively. The output is T


PRED


(t). Weights w


1


and w


2


and bias θ(t) are used.




This network


302


computes T


PRED


(t) as follows:








u


(


t


)=


w




1


*(


T




TIP


(


t


)−


T




TIP


(0))+


W




2


*(


T




CENTER


(t)−T


CENTER


(0))−θ










y


(


t


)=2/(1+exp(−0.002*


u


(


t


)))−1










T




PRED


(


t


)=150*


y


(


t


)+37






The relationship between y(t) and u(t) is an activation function, which, in the above network


302


, is a sigmoidal function. The factor “150” in the last equation is required because of the chosen activation function. The term “37” reflects the temperature of the tissue before ablation, i.e., body temperature. The coefficients are derived based on the experimental data presented above in Section III(A) with the apparatus shown in

FIG. 6






The weights w


1


and w


2


and the bias term θ(t) were set based upon training on four experimental sets of data. During the training sessions, the weights and bias terms were updated using the back-propagation algorithm described in S. Haykin, “Neural Networks,” IEEE Press (New York), 1994. The final values were computed by averaging the results in the four training sessions.





FIG. 11

presents a comparison, for an electrode-tissue angle of 90°, of the temperature variations with time, at a constant power of 7 W, between actual and predicted maximal tissue temperature. The comparison was conducted after the training sessions and with data different than the data used for training, acquired using the apparatus shown in FIG.


6


. The comparison shows good correspondence between the two control inputs, once overshoot and settling time converge to zero.




B. Prediction Based Upon Fuzzy Logic




The dependence of maximum tissue temperature on T


1


and T


2


can also be approximated using fuzzy logic.

FIG. 12

shows an alternative embodiment of the temperature processor


66


which derives P


DEMAND


using fuzzy logic control principles. In this implementation, the processor


66


includes a fuzzifier


502


, which receives as inputs the temperature signals T


1


(t) and T


2


(t) from the sensing elements


30


and


32


. The fuzzifier


502


also receives T


SET


as input, either as a constant value or a value that changes over time. The fuzzifier


502


converts the pairs of T


1


(t) and T


2


(t) input data to fuzzy inputs based upon reference to T


SET


on a relative basis. For example, the fuzzy inputs can determine the degree (or membership function) to which a given pair of T


1


(t) and T


2


(t) is, compared to T


SET


, “cool” or “warm” or “warmer” or “hot”.




These fuzzy inputs are passed through an I/O mapper


504


which converts them to fuzzy outputs by translating the inputs into descriptive labels of power. This is accomplished, for example, by using linguistic “if . . . then” rules, like “if the fuzzy input is . . . then the fuzzy output is . . . ” Alternatively, more complex mapping matrical operators can be used.




For example, if the T


1/2


pair is “cool,” the I/O mapper


504


outputs the descriptive label “Largest Positive,” to indicate that a large relative increase in power is required. By the same token, if the T


1/2


pair is “hot,” the I/O mapper


504


outputs the descriptive label “Largest Negative,” to indicate that large relative decrease in power is required. The intermediate fuzzy inputs “warm” and “warmer” produce intermediate descriptive labels as fuzzy outputs, such as “Smallest Positive” and “Smallest Negative.”




These fuzzy outputs are passed through a defuzzifier


506


. The defuzzifier


506


also receives actual power P(t) as an input, since the fuzzy outputs refer to variations in P(t). Based upon P(t) and the variations required based upon the fuzzy outputs, the defuzzifier


506


derives P


DEMAND


(t).




To define proper reference sets and the rules of the I/O mapper


504


, it may be required that the fuzzy logic controller be trained on a known set of data before use.




IV. Other Temperature Sensing Embodiments




A. Multiple Electrodes





FIG. 13

shows a flexible ablating element


74


, which includes multiple, electrode elements, designated E


1


, E


2


, and E


3


arranged in a spaced apart, segmented relationship along a flexible catheter body


76


. The electrode elements can comprise generally rigid electrode rings, or spirally wound lengths of wire (as

FIG. 13

shows), or electrode material coated upon the body


76


.




As

FIG. 13

shows, each electrode element E


1


, E


2


, and E


3


carries at least one and, preferably, at least two, temperature sensing elements, designated S


1


to S


6


. When the electrode elements exceed about 10 mm in length (as

FIG. 13

contemplates), the temperature sensing elements S


1


to S


6


are preferably located at the edges of electrode elements E


1


to E


3


, where the electrode elements abut the underlying, non-electrically-conductive catheter body


76


. These sensing elements S


1


to S


6


are positioned to sense the temperature of the electrode elements.




The sensing elements S


1


to S


6


can be secured to the electrode elements in various ways. For example, they can be secured to the inside surface of the electrode elements, or sandwiched between the inside surface of the electrode and the underlying flexible body.




Alternatively, the sensing elements S


1


to S


6


can be threaded up through the windings in the electrode elements to lay upon its exterior surface.




Regardless of the particulars, the sensing elements S


1


to S


6


are electrically insulated from the electrode elements, such as, for example, being encapsulated in an epoxy or PTFE coating, as described before.




As

FIG. 13

also shows, additional temperature sensing elements S


7


and S


8


are preferably located between adjacent electrode elements E


1


to E


3


. These temperature sensing elements S


7


and S


8


are positioned to sense tissue temperature between the electrode elements.




In this arrangement, each sensing element S


7


and S


8


is threaded through the flexible body between adjacent electrode segments E


1


to E


3


. When the sensing element


80


comprises a thermocouple, an epoxy material, such as Master Bond Polymer System EP32HT (Master Bond Inc., Hackensack, N.J.), encapsulates the thermocouple junction, while also securing it to the flexible body. Alternatively, the thermocouple junction can be coated in a thin layer of polytetrafluoroethylene (PTFE) material. When used in thicknesses of less than about 0.002 inch, these materials have the sufficient insulating properties to electrically insulate the thermocouple junction from the associated electrode segment E


1


to E


3


. The use of such materials typically will not be necessary when thermistors are used, because conventional thermistors are already encapsulated in an electrically insulating and thermally conducting material.




Further details of such multiple electrode structures are disclosed in copending U.S. application Ser. No. 08/286,930, filed Aug. 8, 1994, entitled “Systems and Methods for Controlling Tissue Ablation Using Multiple Temperature Sensing Elements” and its continuation-in-part application Ser. No. 08/439,824, filed May 12, 1995, entitled “Systems and Methods for Controlling Tissue Ablation Using Multiple Temperature Sensing Elements.”




In this embodiment, the temperature acquisition system


64


is coupled to all temperature sensing elements S


1


to S


8


. The system


64


continuously samples at prescribed time periods, t, the analog signals generated by all the sensing elements S


1


to S


8


based upon locally sensed temperature conditions. The system


64


converts the separate analog signals of the sensing elements S


1


to S


8


into individual, proportional digital signals. The digital signals from sensing elements S


7


and S


8


located between adjacent electrode elements approximate inter-electrode tissue temperatures T


n,1


(t), where n identifies a particular one of the sensing elements S


7


or S


8


. The digital signals from sensing elements S


1


to S


6


located on the electrode elements E


1


to E


3


correspond to electrode temperatures T


k,2


(t), where k identifies a particular one of the sensing elements S


1


to S


6


.




In this embodiment, the temperature processing element


66


is coupled to the temperature acquisition system


64


to receive as input the digital signal temperatures T


n,1


(t) and electrode temperatures T


k,2


(t). The processing element


66


applies prescribed criteria to these actual temperature signals to derive, for the sampled time interval, a prediction of the hottest tissue temperature contacting each electrode element T


mpred


(t), where m identifies a particular electrode element.





FIG. 17

shows, in schematic form, a representative system


200


for applying ablating energy by multiple electrodes based, at least in part, upon local temperature conditions sensed by multiple sensing elements.




In

FIG. 17

, the multiple sensing elements comprise thermocouples


208


,


209


, and


210


individually associated with multiple electrodes


201


,


202


, and


203


. It should be appreciated that more thermocouples could also be associated with each electrode (as

FIG. 13

shows), and/or thermocouples can be located between electrodes (as

FIG. 13

also shows). The system


200


also includes a common reference thermocouple


211


carried within the coupler element


211


for exposure to the blood pool. The common reference thermocouple


211


could also be located externally, for example, in a catheter handle or in the generator, if maintained there at a known temperature. Alternatively, other kinds of temperature sensing elements can be used, like, for example, thermistors, fluoroptic sensors, and resistive temperature sensors, in which case the reference sensor


211


would typically not be required.




The system


200


further includes an indifferent electrode


219


for operation in a uni-polar mode.




The system


200


includes a source


217


of ablating energy. In

FIG. 17

, the source


217


generates radio frequency (RF) energy. The source


217


is connected (through a conventional isolated output stage


216


) to an array of power switches


214


, one for each electrode region


201


,


202


, and


203


. A connector


212


(carried by the probe handle) electrically couples each electrode region


201


,


203


,


203


to its own power switch


214


and to other parts of the system


200


.




The system


200


also includes a microcontroller


231


coupled via an interface


230


to each power switch


214


. The microcontroller


231


turns a given-power switch


214


on or off to deliver RF power from the source


217


individually to the electrode regions


201


,


202


, and


203


. The delivered RF energy flows from the respective electrode region


201


,


202


, and


203


, through tissue, to the indifferent electrode


219


, which is connected to the return path of the isolated output stage


216


.




The power switch


214


and interface


230


configuration can vary according to the type of ablating energy being applied.

FIG. 18

shows a representative implementation for applying RF ablating energy.




In this implementation, each power switch


214


includes an N-MOS power transistor


235


and a P-MOS power transistor


236


coupled in between the respective electrode region


201


,


202


, and


203


and the isolated output stage


216


of the power source


217


.




A diode


233


conveys the positive phase of RF ablating energy to the electrode region. A diode


234


conveys the negative phase of the RF ablating energy to the electrode region. Resistors


237


and


238


bias the N-MOS and P-MOS power transistors


235


and


236


in conventional fashion.




The interface


230


for each power switch


214


includes two NPN transistors


239


and


240


. The emitter of the NPN transistor


239


is coupled to the gate of the N-MOS power transistor


235


. The collector of the NPN transistor


240


is coupled to the gate of the P-MOS power transistor


280


.




The interface for each power switch


214


also includes a control bus


243


coupled to the microcontroller


231


. The control bus


243


connects each power switch


214


to digital ground (DGND) of the microcontroller


231


. The control bus


243


also includes a (+) power line (+5V) connected to the collector of the NPN transistor


239


and a (−) power line (−5V) connected to the emitter of the NPN interface transistor


240


.




The control bus


243


for each power switch


214


further includes an E


SEL


line. The base of the NPN transistor


239


is coupled to the E


SEL


line of the control bus


243


. The base of the NPN transistor


240


is also coupled the E


SEL


line of the control bus


243


via the Zener diode


241


and a resistor


232


. E


SEL


line connects to the cathode of the Zener diode


241


through the resistor


232


. The Zener diode


241


is selected so that the NPN transistor


240


turns on when E


SEL


exceeds about 3 volts (which, for the particular embodiment shown, is logic 1).




It should be appreciated that the interface


230


can be designed to handle other logic level standards. In the particular embodiment, it is designed to handle conventional TTL (transistor transfer logic) levels.




The microcontroller


231


sets E


SEL


of the control bus


243


either at logic 1 or at logic 0. At logic 1, the gate of the N-MOS transistor


235


is connected to (+) 5 volt line through the NPN transistors


239


. Similarly, the gate of the P-MOS transistor


236


is connected to the (−) 5 volt line through the NPN transistor


240


. This conditions the power transistors


235


and


236


to conduct RF voltage from the source


217


to the associated electrode region. The power switch


214


is “on.”




When the microcontroller


231


sets E


SEL


at logic 0, no current flows through the NPN transistors


239


and


240


. This conditions the power transistors


235


and


236


to block the conduction of RF voltage to the associated electrode region. The power switch


214


is “off.”




The system


200


(see

FIG. 17

) further includes two analog multiplexers (MUX)


224


and


225


. The multiplexers


224


and


225


receive voltage input from each thermocouple


208


,


209


,


210


, and


211


. The microcontroller


231


controls both multiplexers


224


and


225


to select voltage inputs from the multiple temperature sensing thermocouples


208


,


209


,


210


, and


211


.




The voltage inputs from the thermocouples


208


,


209


,


210


, and


211


are sent to front end signal conditioning electronics. The inputs are amplified by differential amplifier


226


, which reads the voltage differences between the copper-wires of the thermocouples


208


/


209


/


210


and the reference thermocouple


211


. The voltage differences are conditioned by element


227


and converted to digital codes by the analog-to-digital converter


228


. The look-up table


229


converts the digital codes to temperature codes.




In one preferred implementation, the microcontroller


316


operates the power switch interface


230


to deliver RF power from the source


217


in multiple pulses of duty cycle 1/N, where N is the number of electrode segments.




With pulsed power delivery, the amount of power (P


E(J)


) conveyed to each individual electrode region E(J) is expressed as follows:








P




E(J)


˜AMP


E(J)




2


×DUTYCYCLE


E(J)








where:




AMP


E(J)


is the amplitude of the RF voltage conveyed to the electrode region E(J), and




DUTYCYCLE


E(J)


is the duty cycle of the pulse, expressed as follows:







DUTYCYCLE

E


(
J
)



=


TON

E


(
J
)





TON

E


(
J
)



+

TOFF

E


(
J
)















where:




TON


E(J)


is the time that the electrode region E(J) emits energy during each pulse period,




TOFF


E(J)


is the time that the electrode region E(J) does not emit energy during each pulse period.




The expression TON


E(J)


+TOFF


E(J)


represents the period of the pulse for each electrode region E(J).




In this mode, the microcontroller


231


collectively establishes duty cycle (DUTYCYCLE


E(J)


) of 1/N for each electrode region (N being equal to the number of electrode regions).




The microcontroller


231


may sequence successive power pulses to adjacent electrode regions so that the end of the duty cycle for the preceding pulse overlaps slightly with the beginning of the duty cycle for the next pulse. This overlap in pulse duty cycles assures that the source


217


applies power continuously, with no periods of interruption caused by open circuits during pulse switching between successive electrode regions.




In this mode, the microcontroller


231


cycles in successive data acquisition sample periods. During each sample period, the microcontroller


231


selects individual sensors S(J,K), and voltage differences are read by the predictor


290


(through MUX


225


) and converted to temperature codes T


PRED


, which are transmitted to the controller


215


.




The predictor


290


receives the temperature codes. In the preferred implementation, when there are multiple temperature sensing elements on a given electrode element, the predictor selects as T


k,2


the hottest of the electrode temperatures sensed by the sensing elements on the electrode element. Also, when the electrode element is bounded by both side by a tissue temperature sensing element, the controller predictor also selects as T


n,1


the hottest of the tissue temperatures sensed by adjacent tissue sensing elements.




Using the selected values of T


n,1


(t) and T


k,2


(t), the predictor derives T


M,PRED


(t) in any of the manners above described for each electrode element.




In this mode, the controller


215


compares the predicted temperature T


PRED


for each electrode during each data acquisition period to a set point temperature T


SET


. Based upon this comparison, the controller


215


varies the amplitude AMP


E(J)


of the RF voltage delivered to the electrode region, while the microcontroller


231


maintains the DUTYCYCLE


E(J)


for that electrode region and all other electrode regions, to establish and maintain T


PRED


at the set point temperature T


SET


.




The manner in which the controller


215


governs AMP


E(J)


can incorporate proportional control methods, proportional integral derivative (PID) control methods, or fuzzy logic control methods.




B. Self-Heated Temperature Sensing Element





FIG. 14

shows another alternative embodiment of an electrode


78


with multiple temperature sensing elements


80


and


82


. In

FIG. 14

, both temperature sensing elements


80


and


82


are connected by soldering or by thermally conducting adhesive to the thermal mass of the electrode


78


.




Alternatively (as

FIG. 15

shows), the sensing element


80


can be located to sense tissue temperature, as sensing element


30


in FIG.


4


.




In addition a resistance heating element


84


is provided for the purpose of heating the thermal mass of the electrode


78


. In the illustrated embodiment shown in

FIG. 14

, the heating element


84


extends in intimate contact about the metal steering spring


52


. As the heating spring


52


heats up, the heat is conducted to the thermal mass of the electrode


78


.




Alternatively (as

FIG. 15

shows), the heating element


84


can be wrapped about a portion of the electrode


78


under the catheter body


22


. In either embodiment, the heating element


84


is located in good thermal conductive contact with the electrode for ohmic heating of the element


84


with DC energy to thereby heat the electrode


78


by conductive heat transfer.




The heating element


84


can comprise an insulated constantant wire having a high resistance, or Nichrome or insulated toaster wire having the same characteristic. As

FIG. 15

shows, the heating wire


84


is mated with low resistance copper wire


85


close to the electrode


78


. The copper wire


85


extends the rest of the way through the catheter body


22


.




The distance (Δx in

FIG. 15

) between the two sensing elements


80


and


82


should preferably be maximized to the fullest extent possible, given the size of the electrode


78


. For example, for an 8F/4 mm electrode, Δx should be at least 3 mm.





FIG. 16

shows a system


400


including an electrode


402


having two temperature sensors TS


1


and TS


2


. The electrode


402


also includes the heating element HE


84


heated by the heater


404


. The electrode


402


is coupled to the RF power source


406


.




The temperatures read by TS


1


and TS


2


(T


1


and T


2


) are acquired by the temperature acquisition system


408


. The system


400


operates in two phases.




During this first phase, no ablating energy is directly applied to the electrode


402


. HE is actuated by the heater


404


so that T


2


is kept about a set value T


heat













set


. The temperature controller


410


which controls the heater


404


can use appropriate control techniques, such as PID, etc.




During this phase, the temperatures T


1


and T


2


are acquired by the acquisition system


408


. The electrical power generated by the heater


404


is also measured, P


heater


.




T


1


, T


2


and P


heater


are inputted to a processing system


412


, which, based upon the distance Δx between temperature sensing elements TS


1


and TS


2


and the whether TS


1


is sensing electrode or tissue temperature, computes the heat loss, Q


loss


, and the temperature spatial gradient ΔT/Δx. The processing system


412


can acquire information concerning the electrode configuration from the physician, or by a read-only-memory chip and the equivalent associated with the electrode which the processing system


412


can interrogate. The heat loss, Q


loss


will depend on the thermal conductivity, density and heat capacity of the metal of the electrode


402


, the amount of electrical and thermal contact between tissue and electrode, and the convective cooling induced by the blood flow. Therefore, Q


loss


and ΔT/Δx are indications of the present status of the electrical-thermal system at the tissue-electrode-blood interface. This status information is later used to predict and control the tissue temperature during ablation in the second phase.




In the second phase, ablation energy is applied to tissue through the electrode


402


. The values of T


1


, T


2


, Q


loss


, ΔT/Δx, T


heat













set


, and P


heater


are fed as inputs to a predictor


414


.




The predictor


414


includes in look-up table form relationships among T


1


, T


2


, Q


loss


, ΔT/Δx, T


heat













set


, P


heater


and T


PRED


. The inputs to the table are T


1


, T


2


, Q


loss


, ΔT/Δx, T


heat













set


P


heater


, and the output of the table is T


PRED


. The look-up table is constructed based on experimental data acquired with an apparatus similar to that shown in

FIG. 6

, using an electrode like that shown in

FIGS. 14 and 15

. The table correlates experimentally measured T


1


, T


2


, Q


loss


, ΔT/Δx, T


heat













set


, P


heater


to experimentally measured maximum tissue temperature. The output T


PRED


of the look-up table is best-fitted to the experimental data.




The values of Q


loss


, ΔT/Δx, T


heat













set


, P


heater


taken during the first phase in connection with T


1


and T


2


characterize the system for input to the table. The current status of T


1


and T


2


taken during the second phase provide from the table a unique output predicting the maximal tissue temperature.




The predictor


414


outputs the predicted tissue temperature T


PRED


. T


PRED


and a set temperature value T


ABL













set


are fed as inputs to a controller


416


, which controls the RF power source


406


. The controller


416


controls predicted tissue temperature about T


ABL













set


.




The illustrated and preferred embodiments envision the use of micro-processor controlled components using digital processing to, analyze information and generate feedback signals. It should be appreciated that other logic control circuits using micro-switches, AND/OR gates, invertors, and the like are equivalent to the micro-processor controlled components and techniques shown in the preferred embodiments. It should also be appreciated that the algorithms disclosed in this Specification lend themselves to implementation using either digital or analog devices.




Various features of the invention are set forth in the claims that follow.



Claims
  • 1. A method of predicting a maximum temperature of body tissue to be heated, comprising:placing an electrode adjacent the body tissue to create an electrode-tissue interface; heating the thermal mass of the electrode to determine an electrode-tissue interface characterization indicator; transmitting RF heating energy to the electrode and measuring first and second temperatures at the electrode-tissue interface; and determining a maximum predicted tissue temperature based at least in part on the determined electrode-tissue interface characterization indicator and the first and second measured temperatures.
  • 2. The method of claim 1, wherein the electrode is placed in contact with the body tissue.
  • 3. The method of claim 1, wherein the electrode-tissue interface characterization indicator comprises one of heat loss and spatial temperature gradient of the electrode.
  • 4. The method of claim 1, wherein the electrode-tissue interface characterization indicator is indicative of one or more of the thermal conductivity, density, and heat capacity of the electrode, the amount of electrical and thermal contact between the tissue and the electrode, and the convective cooling induced by a flow of liquid along the body tissue.
  • 5. The method of claim 1, wherein the maximum predicted tissue temperature is determined by comparing the electrode-tissue interface characterization indicator and the first and second measured temperatures to a look-up table that correlates experimentally measured data with an experimentally measured maximum tissue temperature.
  • 6. The method of claim 1, further comprising comparing the maximum predicted tissue temperature with a set temperature value and controlling the transmission of RF heating energy based on the comparison.
  • 7. The method of claim 1, wherein the body tissue is heart tissue.
  • 8. A method of determining an electrode-tissue interface characterization indicator, comprising:placing an electrode adjacent the body tissue to create an electrode-tissue interface; transmitting RF energy to the electrode for a short duration and measuring first and second temperatures from resultant tissue-electrode interface heating of the thermal mass of the electrode; and determining an electrode-tissue interface characterization indicator based at least in part from the first and second measured temperatures.
RELATED APPLICATION DATA

This application is a Continuation application of Ser. No. 09/034,977, filed on Mar. 4, 1998 now U.S. Pat. No. 6,293,943, which is a continuation of 08/482,361, filed on Jun. 7, 1995 (now abandoned).

US Referenced Citations (14)
Number Name Date Kind
5122137 Lennox Jun 1992 A
5180896 Gibby Jan 1993 A
5383922 Zipes et al. Jan 1995 A
5456682 Edwards et al. Oct 1995 A
5458596 Lax et al. Oct 1995 A
5536267 Edwards et al. Jul 1996 A
5540679 Fram et al. Jul 1996 A
5623940 Daikuzono Apr 1997 A
5688267 Panescu et al. Nov 1997 A
5735846 Panescu et al. Apr 1998 A
6022346 Panescu et al. Feb 2000 A
6053912 Panescu et al. Apr 2000 A
6245061 Panescu et al. Jun 2001 B1
6293943 Panescu et al. Sep 2001 B1
Foreign Referenced Citations (2)
Number Date Country
WO 9210142 Jun 1992 WO
WO 9315664 Aug 1993 WO
Continuations (2)
Number Date Country
Parent 09/034977 Mar 1998 US
Child 09/962662 US
Parent 08/482361 Jun 1995 US
Child 09/034977 US